Literature DB >> 14732752

Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation.

Jun Xu1, Guanggen Cui, Fardad Esmailian, Mark Plunkett, Daniel Marelli, Abbas Ardehali, Jonah Odim, Hillel Laks, Luyi Sen.   

Abstract

BACKGROUND: Remodeling occurs in both ventricle and atrium in dilated cardiomyopathy and heart failure. However, the alteration of atrial extracellular matrix components during remodeling and its effect on the electrical remodeling and atrial arrhythmia have never been explored. METHODS AND
RESULTS: Atrial tissue samples of 53 explanted hearts from patients with dilated cardiomyopathy and end-stage heart failure who underwent heart transplantation were examined. Nineteen patients had permanent atrial fibrillation (PmAF), 18 had persistent AF (PsAF), and 16 had no documented AF (NAF). Sixteen donor left atria (LA) were used as controls (CNs). Western Blot analysis revealed a selective downregulation of tissue inhibitor of metalloproteinase (TIMP)-2 in PmAF and PsAF groups compared with the NAF and CN groups and an upregulation of atrial metalloproteinase (MMP)-2 that was most pronounced in the PmAF group followed by the PsAF and NAF groups. Immunofluorescent staining revealed that in the LA, type I collagen volume fraction (CVF-I) increased significantly in the PmAF group followed by the PsAF and NAF groups compared with that in CN. LA CVF-I significantly correlated with LA dimension and TIMP-2 to MMP-2 ratio. In the PsAF group, CVF-I/CVF-III ratio was significantly correlated with AF duration and the frequency of AF recurrence.
CONCLUSIONS: Atrial extracellular matrix remodeling manifested by the selective downregulation of TIMP-2 along with upregulation of MMP-2 and CVF-I in the atrium is associated with the development of sustained atrial fibrillation in patients with cardiomyopathy and heart failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732752     DOI: 10.1161/01.CIR.0000109495.02213.52

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  100 in total

Review 1.  Extracellular Matrix and Regenerative Therapies from the Cardiac Perspective.

Authors:  Arin Dogan; Mahmut Parmaksız; A Eser Elçin; Y Murat Elçin
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

2.  Angiotensin II in atrial structural remodeling: the role of Ang II/JAK/STAT3 signaling pathway.

Authors:  Liuying Zheng; Xiaogang Jia; Cheng Zhang; Dong Wang; Zhongnan Cao; Jin Wang; Xinping Du
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 3.  [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].

Authors:  U Ravens; E Wettwer; U Schotten; R Wessel; D Dobrev
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

4.  Qiliqiangxin attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in rabbits.

Authors:  Hou Tingting; Liu Guangzhong; Zang Yanxiang; Yu DongDong; Sun Li; Weimin Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-09       Impact factor: 3.000

5.  Association of Left Atrial Local Conduction Velocity With Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.

Authors:  Kotaro Fukumoto; Mohammadali Habibi; Esra Gucuk Ipek; Sohail Zahid; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; David Spragg; Hiroshi Ashikaga; Natalia Trayanova; Gordon F Tomaselli; John Rickard; Joseph E Marine; Ronald D Berger; Hugh Calkins; Saman Nazarian
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-03

6.  Age-related atrial fibrosis.

Authors:  Felix Gramley; Johann Lorenzen; Christian Knackstedt; Obaida R Rana; Erol Saygili; Dirk Frechen; Sven Stanzel; Francesco Pezzella; Eva Koellensperger; Christian Weiss; Thomas Münzel; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2008-10-07

Review 7.  Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants.

Authors:  Anke C Fender; Reza Wakili; Dobromir Dobrev
Journal:  Pharmacol Res       Date:  2019-05-02       Impact factor: 7.658

8.  Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation.

Authors:  Naoko Sasaki; Yasuo Okumura; Ichiro Watanabe; Hiroaki Mano; Koichi Nagashima; Kazumasa Sonoda; Rikitake Kogawa; Kimie Ohkubo; Toshiko Nakai; Atsushi Hirayama
Journal:  J Interv Card Electrophysiol       Date:  2014-02-20       Impact factor: 1.900

9.  Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.

Authors:  Karni S Moshal; Srinivas M Tipparaju; Thomas P Vacek; Munish Kumar; Mahavir Singh; Iluiana E Frank; Phani K Patibandla; Neetu Tyagi; Jayesh Rai; Naira Metreveli; Walter E Rodriguez; Michael T Tseng; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

10.  Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1.

Authors:  Karni S Moshal; Munish Kumar; Neetu Tyagi; Paras K Mishra; Naira Metreveli; Walter E Rodriguez; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.